Aurinia Pharmaceuticals Inc.
AUPH
12 insider filings · Latest: Mar 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 11 8:11 PM | PETER GREENLEAF | Proposed Sale | 3,136,201 | $15.84 | $49.7M | — | View → |
| May 11, 2026 | May 11 8:10 PM | MATTHEW MAXWELL DONLEY | Proposed Sale | 717,688 | $15.84 | $11.4M | — | View → |
| May 11, 2026 | May 11 8:07 PM | JOSEPH MILLER | Proposed Sale | 500,503 | $15.84 | $7.9M | — | View → |
| Mar 3, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 184,208 | $14.22 | $2.6M | 12,229,500(I) | View → |
| Mar 2, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 199,353 | $14.26 | $2.8M | 12,045,292(I) | View → |
| Feb 27, 2026 | Mar 3 10:35 PM | Kevin TangDirector | Purchase | 516,439 | $13.99 | $7.2M | 11,845,939(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 9:14 PM | Joseph M MillerChief Financial Officer | Grant/Award | 95,700 | $13.97 | 95,700(D) | View → |
| Feb 27, 2026 | Mar 3 9:14 PM | Matthew Maxwell DonleyChief Operating Officer | Grant/Award | 97,256 | $13.97 | 97,256(D) | View → |
| Feb 27, 2026 | Mar 3 9:13 PM | Peter GreenleafDirector, Chief Executive Officer | Grant/Award | 328,424 | $13.97 | 328,424(D) | View → |
| Feb 27, 2026 | Mar 3 9:13 PM | Greg KeenanSVP, Chief Medical Officer | Grant/Award | 67,870 | $13.97 | 67,870(D) | View → |
| Feb 27, 2026 | Mar 3 9:12 PM | Stephen P. RobertsonEVP, General Counsel | Grant/Award | 98,813 | $13.97 | 98,813(D) | View → |